Hyperhidrosis Botox

Hyperhidrosis means sweating beyond what is needed for normal thermoregulation. For primary focal axillary hyperhidrosis, botulinum toxin type A is a well-established treatment. The source chapter reports a recommended dose of 50 units of onabotulinumtoxinA per axilla and an average treatment effect of approximately 6 to 7 months. Treatment begins with assessment for secondary causes and accurate mapping of the sweating area.

What is hyperhidrosis?

Hyperhidrosis (HH) is excessive sweating beyond what the body needs for temperature control. The source chapter classifies hyperhidrosis as generalized or focal. Generalized sweating is more often secondary to an underlying cause, while focal sweating is commonly idiopathic and may affect the axillae, palms, soles, face/scalp, groin, chest, back, or other localized regions.

Primary focal hyperhidrosis is typically visible and persistent, with no apparent secondary cause. The source lists features such as bilateral symmetry, onset before age 25, family history, cessation during sleep, weekly episodes, and interference with daily activities as useful diagnostic characteristics.

The source states that the first important step is to rule out secondary causes of sweating, including hyperthyroidism and medication effects. History and physical examination are usually sufficient to guide this distinction.

How common is excessive sweating?

The chapter cites an estimated overall prevalence of 4.8%, with higher prevalence reported in teenagers. Among affected anatomic sites in the cited population, the axilla was the most common, followed by craniofacial, palmar, and plantar involvement.

How hyperhidrosis can affect daily life

Hyperhidrosis is not simply a cosmetic concern. The source describes substantial effects on clothing choices, social interaction, intimacy, work and daily routines. It also cites increased embarrassment and an association with higher rates of anxiety and depression in affected patients. Repeated moisture may also increase the risk of certain bacterial, viral and fungal skin infections.

The Hyperhidrosis Disease Severity Scale (HDSS) is a validated clinical tool used to assess how much sweating interferes with daily activity and to monitor treatment response.

How is the sweating area identified before Botox?

The Minor starch-iodine test is a simple colorimetric method used to map active sweating. The source describes drying the skin, applying iodine, allowing it to dry, then dusting the area with a small amount of starch. Sweat produces a purple-to-black reaction, helping outline the active treatment field. The test maps surface area but is not quantitative.

Sweating is unusual within the sympathetic nervous system because eccrine sweat glands are stimulated predominantly by acetylcholine. Botulinum toxin type A prevents acetylcholine release at the neuroglandular junction. When placed in the appropriate intradermal or superficial subcutaneous plane, this produces localized, temporary chemodenervation and reduces sweat output in the treated area.

The chapter notes that onabotulinumtoxinA was FDA-approved for axillary hyperhidrosis in 2004 and describes BoNT as a safe, established and effective treatment for focal axillary hyperhidrosis.

Botox for underarm sweating (axillary hyperhidrosis)

For axillary hyperhidrosis, the source describes treatment of the mapped sweating field with onabotulinumtoxinA. In a cited randomized study of 307 patients, 94% of the active-treatment group achieved at least a 50% reduction in sweating compared with 36% in the placebo group.

Source protocol summary : 50 units of onabotulinumtoxinA per axilla, placed at the dermal-subcutaneous level at approximately 1.5 cm intervals. The number of injection points depends on the surface area; the chapter describes an average of approximately 10 to 15 injections per axilla.

Exact product choice, dose, dilution, treatment field, injection depth and retreatment strategy must be determined by a qualified clinician after examination. The source also describes higher-dose approaches in selected patients, but these are individualized and should not be copied as a universal protocol.

How long does Botox for sweating last?

The average efficacy described in the source is approximately 6 to 7 months. Duration varies considerably between patients and may also vary between treatment sessions in the same patient. The source cites evidence that repeated treatment can be associated with longer duration in some patients.

Can Botox be used for sweating outside the underarms?

Yes, but the regulatory status and technique differ by area. The source states that onabotulinumtoxinA is FDA-approved for axillary hyperhidrosis, while use in other hyperhidrosis regions is off-label. Areas discussed in the chapter include:

• Palmar hyperhidrosis (hands)
• Plantar hyperhidrosis (feet)
• Craniofacial hyperhidrosis (face and scalp)
• Trunk sweating
• Gustatory sweating, including Frey syndrome
• Compensatory sweating after thoracic sympathectomy

Botox for Sweaty Palms

The chapter reports a broad range of doses studied for palmar hyperhidrosis and notes two practical limitations: treatment can be painful and temporary finger or pinch weakness can occur if toxin affects nearby muscles. The source discusses cooling, vibration, topical anesthesia and nerve blocks as methods used to improve tolerability.

Botox for forehead & Scalp Sweating

For craniofacial hyperhidrosis, precise localization is especially important because sweat can flow away from its true point of origin, making the whole scalp or face feel involved. The source recommends superficial, more concentrated treatment in this region to reduce diffusion into the frontalis muscle, which could otherwise contribute to brow ptosis.

Botox for Gustatory Sweating

The chapter describes gustatory sweating after parotid trauma or surgery, including Frey syndrome. Chewing during starch-iodine testing can help localize the active area. Patients should be counselled about the possibility of unwanted facial muscle effects, including smile asymmetry, depending on the treatment field.

Who should not receive botulinum toxin for hyperhidrosis?

Contraindications and cautions listed in the source include :

• Previous allergic reaction to botulinum toxin.
• Injection into an area of active infection or inflammation.
• Pregnancy or breastfeeding.
• Relative caution in neuromuscular-junction disorders such as myasthenia gravis or Eaton-Lambert syndrome.
• Caution with medications that reduce neuromuscular transmission, anticholinergic medications, or muscle relaxants because effects may be potentiated.

Possible side effects

For axillary treatment, the source lists potential adverse effects such as injection-site pain, bruising, headache, muscle soreness, axillary itching, increased facial sweating, or perceived compensatory sweating. Compensatory hyperhidrosis after botulinum toxin is described as rare, although patients may notice sweating from other untreated areas more once their main problem area improves.

In non-axillary regions, side effects depend on local anatomy. Examples discussed include temporary hand weakness after palmar treatment and brow ptosis or facial asymmetry if toxin diffuses into nearby facial muscles.

What should a hyperhidrosis consultation in Abu Dhabi include?

1. Determine whether sweating is focal or generalized and assess for secondary causes.
2. Document the sites involved, severity, triggers, duration and impact on daily life.
3. Use a structured severity tool such as the HDSS when useful.
4. Map the active sweating field, particularly in the axilla, using clinical examination and/or a starch-iodine test.
5. Discuss the treatment area, product, expected duration, discomfort, possible weakness or asymmetry depending on location, and realistic goals.
6. Plan follow-up based on clinical response rather than automatically repeating treatment at a fixed interval.